OncoMatch/Clinical Trials/NCT07781306
PrOspEctive Metastases Imaging (POEM)
Official title: Prospective Complete Histopathological Characterization of Liver Metastases From Colorectal and Breast Carcinoma to Predict the Histopathological Growth Patterns by Medical Imaging - PrOspEctive Metastases Imaging (POEM)
Is NCT07781306 recruiting? Yes, currently enrolling (Oct 2026).
This is a non-interventional, observational study with an optional interventional biobanking activity. Liver metastases of patients undergoing partial hepatectomy will be sampled completely while respecting the orientation used for medical imaging, in order to correlate the histopathological growth patterns in a 3D-map with the imaging characteristics. The full pathological sampling will only use remnant tissue.
Check if I qualifyExtracted eligibility criteria
Cancer type
Colorectal Cancer
Breast Carcinoma
Disease stage
Metastatic disease required
Prior therapy
Cannot have received: radiofrequency ablation
Cannot have received: transarterial chemoembolization
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07781306 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior radiofrequency ablation, transarterial chemoembolization disqualifies patients from enrollment.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages